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The activity of chaperone-mediated autophagy
(CMA), a catabolic pathway for selective degradation
of cytosolic proteins in lysosomes, decreases with
age, but the consequences of this functional decline
in vivo remain unknown. In this work, we have gener-
ated a conditional knockout mouse to selectively
block CMA in liver. We have found that blockage
of CMA causes hepatic glycogen depletion and
hepatosteatosis. The liver phenotype is accompa-
nied by reduced peripheral adiposity, increased en-
ergy expenditure, and altered glucose homeostasis.
Comparative lysosomal proteomics revealed that
key enzymes in carbohydrate and lipid metabolism
are normally degraded by CMA and that impairment
of their regulated degradation contributes to the
metabolic abnormalities observed in CMA-defective
animals. These findings highlight the involvement of
CMA in regulating hepatic metabolism and suggest
that the age-related decline in CMA may have a
negative impact on the energetic balance in old
organisms.
INTRODUCTION
Autophagy is the process by which cellular components are
delivered to lysosomes for degradation (Mizushima et al.,
2008). In chaperone-mediated autophagy (CMA) (Kaushik and
Cuervo, 2012), a pathway present in all mammalian cells, cyto-
solic proteins targeted for degradation are identified by the
chaperone hsc70 that recognizes a pentapeptide motif in their
amino acid sequence (Chiang et al., 1989; Chiang and Dice,
1988). Once the chaperone-substrate complex reaches the
lysosomal membrane, the substrate protein binds the cytosolic
tail of the lysosome-associated membrane protein type 2A
(LAMP-2A) (Cuervo and Dice, 1996) and drives its multimeriza-
tion into a translocation complex that transports the substrate
protein into the lysosomal lumen for degradation (Bandyopad-
hyay et al., 2008). LAMP-2A is the only one of three spliced var-
iants of the lamp2 gene (Eskelinen et al., 2005) that participates in
CMA (Cuervo and Dice, 1996, 2000b; Massey et al., 2006).Cell MeCMA has been extensively studied in liver where it is induced
to mediate selective removal of proteins damaged by insults
such as oxidative stress, hypoxia, or proteotoxicity (Cuervo
et al., 1999; Hubbi et al., 2013; Kiffin et al., 2004; Koga et al.,
2011). CMA is activated by nutritional changes such as starva-
tion (Cuervo et al., 1995) or in response to lipid overload (Rodri-
guez-Navarro et al., 2012). Nutritional challenges also drive other
autophagic pathways, but temporal differences in the activation
of each pathway and the selectivity of CMA for proteins bearing
the targeting motif make it likely that a distinct subproteome un-
dergoes degradation by CMA. Some glycolytic enzymes such
as glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
pyruvate kinase have been characterized as CMA substrates in
liver (Aniento et al., 1993) and cancer cells (Kon et al., 2011; Lv
et al., 2011), respectively. However, the physiological relevance
of their nutrition-regulated degradation by CMA and the overall
impact on metabolism of the malfunction of this autophagic
pathway in vivo remain unknown.
In this work, we have generated a mouse with a conditional
knockout for LAMP-2A, the CMA limiting component, to study
the physiological function of CMA in liver and the consequences
of the failure of this pathway. We have found that loss of CMA
leads to pronounced alterations in hepatic carbohydrate and
lipid metabolism which have a negative impact on the overall en-
ergetic balance of the organism. Using comparative proteomics,
we have demonstrated that the liver subproteome normally
degraded by CMA includes key enzymes in carbohydrate and
lipid metabolism. These findings unveil a previously unknown
role of CMA in the control of liver metabolic homeostasis and
lead us to propose that the decline of CMAwith agemay underlie
the basis of metabolic dysregulation in old organisms.
RESULTS
A Mouse Model with Defective Hepatic CMA
To study the consequences of defective hepatic CMA, we
generated a liver-specific conditional knockout mouse for
LAMP-2A, the limiting component in CMA (Cuervo and Dice,
2000a). We used the Cre-loxP system to conditionally disrupt
the 508bp region in exon 8 of the lamp2 gene that encodes
for the cytosolic and transmembrane domains of the LAMP-2A
protein (Gough et al., 1995). Crossing mice carrying the floxed
LAMP-2A allele (L2AF/F) with mice expressing Cre recombinase
under control of the albumin promoter (Postic et al., 1999) al-
lowed us to generate a liver-specific LAMP-2A knockout mousetabolism 20, 417–432, September 2, 2014 ª2014 Elsevier Inc. 417
igure 1. Liver-Specific L2AKO Mice Are Incompetent for CMA and Display Signs of Liver Damage and Reduced Liver Function
) Schematic of the generation of mice with liver-specific deletion of LAMP-2A.
) RT-PCR quantification of LAMP-2A and LAMP-1 mRNA levels in livers from Albumin-Cre-L2Af/f (L2AKO) and L2Af/f (Control, Ctr) mice, n = 4.
) Immunoblot for LAMP-2A in liver homogenates from the same animal groups (Alb-Cre mice are shown as an additional control).
) Immunohistochemistry for LAMP-2A in liver sections (scale bar, 20 mm).
and F) Immunoblot for the indicated proteins in homogenates (E) and lysosomes (F).
) Quantification of the fraction of mature Cathepsin D relative to total Cathepsin D detected by immunoblot in isolated liver lysosomes, n = 5.
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CMA and Liver Metabolismmodel (Alb-Cre:L2AF/F thereafter referred to as L2AKO; Fig-
ure 1A). L2AKO mice were born at Mendelian frequency and
proportional male/female ratios. Levels of LAMP-2A mRNA and
protein were almost undetectable in livers of L2AKO mice
when compared with L2AF/F mice (Control; Ctr) (Figures 1B
and 1C). Immunohistochemistry demonstrated the selectivity
of LAMP-2A depletion in hepatocytes, but not in endothelial cells
and macrophages (Figure 1D). Levels of LAMP-2A were unal-
tered in other tissues (Figure S1A available online), and liver
levels of other LAMPs in L2AKO mice were comparable, or in
the case of LAMP-2B even slightly higher than in Ctr mice (Fig-
ures 1E and S1B).
Mice with whole lamp2 gene deletion have been previously
generated (Tanaka et al., 2000), but the severe compromise of
other autophagic pathways and defective lysosomal biogenesis
resulting from the loss of all three LAMP-2 isoforms made this
model unsuitable for studying the consequences of only CMA
failure. In contrast to the total L2KO mouse model, we did not
find differences between lysosomes isolated from Ctr and
L2AKO mice in their content of mature hydrolases (cathepsin D
shown in Figures 1F and 1G), enzymatic activities (total liver
and lysosomal b-hexosaminidase activities shown in Figure 1H),
or stability of their membranes (Figure 1I). Blockage of lysosomal
proteolysis in vivo by intraperitoneal injection of leupeptin
confirmed that lysosomal delivery and degradation of cytosolic
proteins such as cyclophillin (a protein lacking the KFERQ motif
and confirmed as a non-CMA substrate [Sahu et al., 2011]) re-
mained unaltered in L2AKO mice (Figure 1J). However, GAPDH,
awell-characterized CMA substrate (Cuervo et al., 1994), was no
longer degraded in lysosomes from L2AKO mice (Figure 1J),
confirming that these animals are unable to internalize and
degrade select proteins by CMA.
In contrast with the severe compromise in macroautophagy
and the accumulation of immature autophagosomes described
in the total lamp2 knockout mice (Tanaka et al., 2000), steady-
state levels of integral autophagosome components (LC3) and
autophagy receptors (p62 or NBR1) (Figure 1K) were normal in
the livers of L2AKO mice. Electron microscopy revealed that
most autophagic vacuoles in these livers were autophagolyso-
somes (postlysosomal fusion) (Figure S1C) and that the ratio au-
tophagosome/autophagolysosome was comparable in L2AKO
mice and Ctr littermates (Figure S1D). These findings confirm
that LAMP-2A is not required for macroautophagy or lysosomal
biogenesis and emphasize the suitability of this mouse model to
study the direct consequences of compromised CMA activity in
liver.
Although liver-specific L2AKO mice did not display any overt
phenotypic manifestations, we found discrete but significantly
elevated serumALT, amarker of hepatocyte damage (Figure 1L),
increased liver apoptosis (Figure S1E), and reduced liver function(H) b-hexosaminidase activity in liver homogenates (left) and isolated lysosomes
(I) Lysosomal membrane stability measured as the percentage of lysosomal b-hex
(J) Immunoblot for the indicated cytosolic proteins in lysosomes isolated from
carboxylase (Pyr. Carb) is shown as a negative control.
(K) Immunoblot for the indicated macroautophagy-related proteins in liver homo
(L) Serum levels of alanine aminotransferase (ALT), n = 4–6.
(M) Time for recovery of the righting reflex after zoxazolamine-induced paralysis
*p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S1.
Cell Meas early as 4 months of age (Figure 1M shows reduction in drug
metabolism and clearance). Suppression of hepatic CMA in vivo
therefore leads to liver damage and a decline in liver function.
Blockage of Hepatic CMA Leads to Hepatosteatosis
L2AKO mice have enlarged and discolored livers which weigh
more than those fromCtr mice (Figures 2A and 2B). Hepatocytes
from L2AKO mice contained round cytosolic structures (Fig-
ure 2C) that stained positive with the neutral lipid dye oil red O
(Figure 2D) and become even more evident after starvation (Fig-
ures 2D and S2A). Ultrastructural analysis confirmed that lipids in
L2AKO livers did not accumulate inside organelles (ER or lyso-
somes) but were instead present as cytosolic lipid droplets
(LDs) in increased number and size (Figure S2B).
The major lipid species that accumulate in the livers of L2AKO
mice were cholesterol esther and triacylglyceride (TG) (Fig-
ure 2E). However, after 24 hr of starvation, L2AKO livers also
accumulated TG precursors, such as free fatty acids (FFAs)
and diacylglycerol (DAG) (Figure 2E), suggestive of inadequate
adaptation to the increased lipid influx from peripheral adipose
tissues. To further evaluate this possibility, we studied the
response of L2AKO mice to acute and chronic lipid challenges.
We treated mice with isoproterenol to acutely stimulate periph-
eral lipolysis at a concentration that increased serum levels of
glycerol and FFA by 2- and 2.9-fold, respectively, 15 min after
treatment and TG content in liver by 30% after two injections
within 24 hr (Figure S2C). LD accumulation after this treatment
was markedly more pronounced in L2AKO livers (Figure 2F)
and the difference in TG content between Ctr and L2AKO livers
became close to 5-fold, whereas cholesterol content remained
unchanged (Figure 2G). Analysis of changes in serum lipids
15 min after the isoproterenol injection revealed no significant
differences in peripheral lipid mobilization between L2AKO and
Ctr mice (Figure 2H), supporting that the abnormal hepatic accu-
mulation of lipids was likely due to a primary defect in the way
that L2AKO livers handled the acute lipid influx.
L2AKO mice were also more sensitive to a chronic increase
in dietary intake of lipids. After 16 weeks on a high-fat diet
(HFD; 60% calories from fat), L2AKO mice had larger and paler
livers (Figures 2I and S2D), more pronounced LDs accumulation
(Figure 2J), and elevated serum ALT levels (Figure S2E). Overall
these findings support that loss of hepatic CMA leads to alter-
ations in fat metabolism that render liversmore vulnerable to lipid
challenges.
Hepatic CMA Loss Leads to a Negative
Energetic Balance
We next analyzed the impact of hepatic CMA blockage on
whole-body energy homeostasis. Liver-specific L2AKO male
mice have discrete but statistically significant lower body(right), n = 7; AUF, arbitrary units of fluorescence.
osaminidase activity detectable in the media upon lysosomal incubation, n = 4.
livers of 24 hr starved mice injected or not with leupeptin (Leup); pyruvate
genates.
, n = 3. All values are mean + SEM. Differences with Ctr were significant for
tabolism 20, 417–432, September 2, 2014 ª2014 Elsevier Inc. 419
(legend on next page)
Cell Metabolism
CMA and Liver Metabolism
420 Cell Metabolism 20, 417–432, September 2, 2014 ª2014 Elsevier Inc.
Cell Metabolism
CMA and Liver Metabolismweights than Ctr male littermates early in life (up to 3.5 months of
age, Figure 3A). These differences are no longer visible after
4months of age (Figure S3A) but can still be elicited by nutritional
deprivation when they lose a significantly greater percentage of
their body weight compared to Ctr littermates (Figure 3B).
L2AKO mice have lower total-body fat mass, further accentu-
ated during starvation (Figure 3C). In fact, starved L2AKO mice
have reduced perigonadal white adipose tissue (WAT) weight
with smaller adipocyte LDs in perigonadal WAT and interscapu-
lar brown adipose tissue (BAT) (Figures 3D and 3E).
To determine the mechanism(s) behind the hepatic accumula-
tion of lipids and the reduced fat mass of L2AKO mice, we used
indirect calorimetry. L2AKO mice on a regular chow diet ex-
hibited significantly higher energy expenditure (EE) than Ctr
mice throughout a 24 hr cycle (Figure 3F), which could not be
attributed to differences in food intake, as meal number and
size were comparable in both groups of animals (Figures S3B–
S3D), or to changes in physical activity, that were surprisingly
reduced in the L2AKO mice (Figures S3E and S3F). The meta-
bolic differences between Ctr and L2AKO mice were exacer-
bated by feeding these mice a HFD which reduced EE in Ctr
mice, but had a significantly smaller impact on lowering the EE
of L2AKO mice (Figure 3G). Despite their higher EE, L2AKO
mice gained more weight on a HFD and displayed increased
fat mass and liver and perigonadal WAT weight gains, further
highlighting their inability to accommodate to this nutritional
stress (Figures S3G–S3I). Using starvation as an opposite nutri-
tional challenge, we found that EE remained significantly higher
in L2AKO mice during the day cycle (Figure 3H). Differences in
EE in both HFD and starvation could not be explained by
changes in physical activity (Figures S3F and S3J), pointing to
an intrinsic metabolic defect.
Next, we analyzed the respiratory exchange ratio (RER) and
found that L2AKO mice consistently have higher RER values
than Ctr mice during the 24 hr cycle, suggestive of enhanced
reliance on the breakdown and oxidation of carbohydrates for
ATP generation (Figure 3I). In fact, even when forcing lipid con-
sumption through starvation, RER values in L2AKO mice re-
mained higher than in Ctr (Figure 3J). Although the increase
in RER in the L2AKO could contribute to the observed higher
EE, the fact that not only CO2 production (VCO2) (Figure S3K)
but also oxygen consumption (VO2) (Figure S3L) was higher
in these animals suggests that the elevated EE is due to an
additional increase in oxygen demand. Collectively, these
findings support that failure of hepatic CMA activity leads toFigure 2. Altered Lipid Metabolism and Hepatosteatosis in Liver-Spec
(A) Representative images of livers from 24 hr starved control (Ctr) and Albumin-
(B) Total liver weight (right) or relative to body weight (b.w.) (left), n = 7.
(C) H&E staining of liver sections from fed, 12 hr, or 48 hr starved mice. Insets sh
(D) Left: Oil red O (ORO) staining of liver sections from fed and 24 hr starved mic
fication of number, area occupied and average area of lipid droplets (LD), n = 4.
(E) Lipid analysis by thin layer chromatography in livers from fed (top) and 24 hr
(F) ORO staining of liver sections from mice after two i.p. injections of isoprote
reference. Insets show higher magnification images.
(G) Levels of triglyceride (TG) and cholesterol (Chol) in livers of the same animals
(H) Serum levels of free fatty acids (FFA) and glycerol before and 15 min after iso
(I) Representative images of livers from mice after 16 weeks on a high-fat diet (H
(J) H&E and ORO staining of liver sections from the same mice in i. All values are m
***p < 0.001. See also Figure S2.
Cell Mechanges in metabolism that compromise the ability to adapt
to the energetic requirements in response to different nutritional
challenges.
CMA-Deficient Livers Exhibit a Switch toward
Carbohydrate Metabolism
The observed higher reliance on carbohydrate catabolism of
L2AKO mice (Figures 3I and 3J) prompted us to further charac-
terize glucose metabolism. We found similar blood glucose
levels in L2AKO and Ctr mice during fed conditions, but over-
night fasting induced a significant drop in blood glucose levels
in the L2AKO mice (Figure 4A). Lower levels of blood glucose
in L2AKO mice in response to short- and long-term fasting
were noticeable even when subjected to a HFD (Figure S4A). In
agreement with their higher RER (Figures 3I and 3J), L2AKO
mice displayed improved glucose tolerance (Figure 4B) even
when placed on a HFD (Figure S4B). The lower blood glucose
levels in L2AKO mice during starvation (Figure 4A) or during
the glucose tolerance test (Figure 4B) were not due to higher
circulating levels of insulin in these mice (Figures S4C and
S4D). Ctr and L2AKO mice exhibited a comparable initial drop
of blood glucose after an insulin challenge (Figure 4C). However,
L2AKO mice displayed a delay in the normalization of blood
glucose levels compared with Ctr littermates, which likely indi-
cates a defect in the counter regulatory response in hepatic
glucose production normally activated to prevent hypoglycemia
(Figure 4C). As an indirect assessment of hepatic gluconeogen-
esis, we measured blood glucose levels following injection of a
pyruvate bolus (converted into glucose in liver) and found a
significantly smaller increase in blood glucose in response to py-
ruvate in L2AKO mice (Figure 4D). Lower glucose levels during
the pyruvate tolerance test are suggestive of reduced hepatic
gluconeogenesis in the L2AKO, but could also be a result
of increased utilization of the injected pyruvate for oxidative
metabolism.
Analysis of hepatic carbohydrate stores confirmed a switch in
L2AKO livers from carbohydrate synthesis and storage to carbo-
hydrate hydrolysis and utilization. Biochemical analysis (Fig-
ure 4E) and PAS staining (Figure 4F) revealed amarked reduction
of glycogen content in livers from L2AKO mice. Low glycogen
storage did not seem to result from accelerated glycogenolysis,
because the fractional decrease in glycogen levels induced by
24 hr starvation was comparable in both groups of animals (Fig-
ure S4E). Instead, we found that L2AKO mice have lower basal
levels of glycogen synthetase (GS) and that a higher percentageific L2AKO Mice
Cre-L2Af/f (L2AKO) mice.
ow higher magnification images (scale bar, 10 mm).
e. Insets show higher magnification images (scale bar, 20 mm). Right: Quanti-
starved (bottom) mice. Values are expressed relative to control values, n = 4.
renol to induce peripheral lipolysis. Untreated L2AKO mice liver is shown as
24 hr after the two-isoproterenol injections, n = 3–4.
proterenol injection in mice, n = 3–4.
FD).
ean + SEM. Differences with Ctr were significant for *p < 0.05, **p < 0.01, and
tabolism 20, 417–432, September 2, 2014 ª2014 Elsevier Inc. 421
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CMA and Liver Metabolismof this enzyme is in an inactive phosphorylated state (pGS) (Fig-
ure S4F). Reduced basal GS activity may be reactive to other
metabolic changes in the L2AKO mice rather than to a primary
defect, because GS is still efficiently activated, and in fact at
higher levels than in Ctr mice, when we stimulate hepatic glyco-
genesis by insulin injection in starved mice (Figure S4G). Lower
glycogen content in the L2AKO mice also cannot be explained
by reduced glycogen synthesis due to decreased sensitivity to
insulin signaling. On the contrary, levels of the downstream
effector pATK were higher in L2AKO mice than in Ctr in fed con-
ditions (Figure S4H), and after insulin injection of starved mice
(Figure S4I). Interestingly, despite increased GS activation and
insulin signaling in L2AKO mice under these conditions, liver
PAS staining at different times after the insulin injection still re-
vealed a lower relative increase in glycogen content in L2AKO
mice (9.23- ± 1.67-fold and 14.73- ± 1.38-fold lower increase
than Ctr mice at 20 and 40 min, respectively, when compared
to the glycogen content before injection) (Figure S4J). Overall
these findings support that livers of L2AKO mice have enhanced
glucose uptake but reduced usage of glucose for glycogen
synthesis.
The lower serum glucose levels upon fasting, reduced
glycogen storage capacity, and higher overall reliance on carbo-
hydrate oxidation for energy production in L2AKO mice led us
to hypothesize that most glucose taken up by the liver may be
directly consumed in this organ through abnormally enhanced
glycolysis. The higher lactate content (Figure 4G) and specific
activity of glycolytic enzymes (GAPDH and PK shown in Fig-
ure 4H) in L2AKO mice livers indirectly supported enhanced
glycolysis. To perform a more direct metabolic analysis, we
measured the extracellular acidification rate (ECAR) of isolated
primary hepatocytes before and after adding the mitochondrial
uncoupler 2,4 dinitrophenol (2,4 DNP) to maximally activate
glycolysis. Hepatocytes isolated from L2AKO mice displayed
significantly higher basal glycolytic rates and maximal glycolytic
capacity (Figure 4I) and higher levels of glycolytic enzymes (Fig-
ure 4J) compared to Ctr hepatocytes. The basal and maximal
glycolytic capacity of the L2AKO hepatocytes remained signifi-
cantly higher than in Ctr even 24 hr after removal of serum
from the culture media, a condition in which glycolysis is nor-
mally suppressed andCMA ismaximally upregulated (Figure 4K).
Immunoblot analysis confirmed that upon starvation, levels of
different glycolytic enzymes in L2AKO livers remained higher
than in Ctr (Figure 4L). In fact, even in ad libitum-fed animals,
the decrease in the levels of some of these glycolytic enzymes
observed in Ctr mice during the period of low food consumption
was no longer noticeable in the livers from L2AKO miceFigure 3. Increased Energy Expenditure and Reduced Peripheral Adip
(A) Changes in body weight with age in control (Ctr) and Albumin-Cre-L2Af/f (L2AK
L2AKO, respectively).
(B) Weight loss (in percentage) in the same animals at 4 months of age after 24 h
(C) Fat mass (top) and lean mass (bottom) as a percent of body weight (b.w.) in
(D) Weight of perigonadal white adipose tissue fat in grams (top) or relative to b.
(E) H&E staining sections of perigonadal white adipose tissue (WAT, top) and in
average size of lipid droplets (LD) in the same tissues.
(F–H) Average values (left) and 24 hr time course (right) of the energy expenditure (
regular chow diet (F; n = 8), fed a HFD for 16 weeks (G; n = 4), or starved for 24
(I and J) Average values of the respiratory exchange ratio (RER) during the light and
a 24 hr starvation period (J), n = 8. All values are mean + SEM. Differences with Ct
Cell Me(Figure S4K), further supporting their inability to modify enzyme
levels to accommodate changing nutrient availability.
CMA Modulates Liver Carbohydrate Metabolism
through Regulated Enzyme Degradation
To unveil how hepatic CMA deficiency leads to metabolic
changes, we first investigated the basis for the observed in-
crease in glycolytic enzymes. Transcriptome analysis showed
that mRNA expression levels of glycolytic enzymes in livers
from Ctr and L2AKO mice did not differ significantly (Figure 5A
and deposited data). To determine if the observed increase in
glycolytic enzymes in L2AKO mouse livers was instead a
consequence of their impaired degradation by CMA, as eight
out of ten glycolytic enzymes contain CMA-targeting motifs in
their sequence and three of them had been previously reported
as bona fide CMA substrates (Aniento et al., 1993; Lv et al.,
2011), we analyzed the lysosomal content and degradation of
these enzymes in vivo. Comparative analysis of the protein
content in the pool of CMA-active lysosomes (those containing
hsc70 in their lumen) isolated from starved Ctr and L2AKO
mice untreated or injected with leupeptin (to block lysosomal
proteolysis) allowed us to distinguish among (1) lysosomal con-
stituent proteins and possible cytosolic contaminants (if their
lysosomal levels were unaffected by proteolysis inhibition), (2)
proteins degraded in lysosomes independently of LAMP-2A
(if their lysosomal levels increased upon proteolysis inhibition
in both Ctr and L2AKO mice; which likely reach this subpopu-
lation of lysosomes via macroautophagy or endocytosis), and
(3) proteins degraded in lysosomes in a LAMP-2A-dependent
manner (if their lysosomal levels increased upon proteolysis in-
hibition only in Ctr mice) (Figure 5B). Immunoblot from these
lysosomal fractions for the glycolytic enzymes that we found
increased in L2AKO livers revealed that they all fit in this third
group (Figures 5C and 5D; pyruvate carboxylase is shown as
a negative control).
Comparative analysis of liver homogenates from fed and
starved mice treated or not with leupeptin revealed that the
marked increase in lysosomal degradation of these enzymes in
Ctr mice was significantly blunted in L2AKO mice (Figures 5E,
5F, and S5B). The fact that the lysosomal degradation of some
of these enzymes was also reduced in normally fed L2AKO
mice, suggesting that CMA contributes to their basal degrada-
tion (Figures 5E, 5F, and S5B). Increased levels of most of these
enzymes in L2AKOmice were even more evident when the cyto-
solic fractions were compared (Figure S5A), further supporting
that the cytosolic pool of these enzymes is the one undergoing
lysosomal degradation. Overall, these results support thatosity in Liver-Specific L2AKO Mice
O) male mice, nR 11 (average group size 14.3 + 0.6 and 13.0 + 0.4 for Ctr and
r (top) or 48 hr (bottom) starvation, n = 11–14.
fed or 24 hr starved mice, n = 9–14.
w. (bottom) in the same mice as in c, n = 3–4.
terscapular brown adipose tissue (BAT, bottom). Right: Quantification of the
EE) during the light and dark cycles or through a 24 hr cycle (Total) in mice fed a
hr (H; n = 8).
dark cycles and Total in mice fed a regular chow diet (I) or during the first 6 hr of
r were significant for *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S3.
tabolism 20, 417–432, September 2, 2014 ª2014 Elsevier Inc. 423
Figure 4. Enhanced Glucose Tolerance and Reduced Hepatic Glycogen Storage in Liver-Specific L2AKO Mice
(A) Blood glucose levels in fed and 8 hr starved control (Ctr) and Albumin-Cre-L2Af/f (L2AKO) mice, n = 6–10.
(B–D) Glucose (B), insulin (C), and pyruvate tolerance (D) tests after overnight fasting, n = 4–8.
(E) Glycogen content in livers from normally fed mice, n = 4.
(F) Periodic acid-Schiff (PAS) staining of liver sections from fed and 24 hr starved mice (scale bar, 20 mm).
(legend continued on next page)
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CMA and Liver MetabolismCMA contributes to modulating intracellular levels of glycolytic
enzymes under basal conditions and in response to nutritional
cues such as starvation.
To identify the subproteome normally degraded by CMA,
we performed a complete quantitative proteomic analysis of
lysosomes isolated from the experimental groups described in
Figure 5B. We found that 55.4% of the proteins associated to
CMA active lysosomes underwent degradation in this compart-
ment and that, among those, 63% qualified as CMA substrates
because of their failure to accumulate in leupeptin-treated
L2AKOmice (Figure 5G). Remarkably, analysis of CMA-targeting
motifs in proteins catalogued as lysosomal substrates in Ctr
mice revealed a very similar percentage (60.9%) of putative
CMA substrates (Figure 5G). Data mining using Ingenuity
Pathway Analysis demonstrated that almost half of the CMA
substrate proteins were involved in cellular metabolism (3-fold
their representation in the total liver proteome), in agreement
with the overrepresentation of cytosolic enzymes in this pool
and in support of their selective targeting to lysosomes (Figures
5H, 5I, S5C, and S5D).
Analysis of the profile of the glycolytic enzymes identified in
the proteomic analysis confirmed our immunoblot data and
the classification of five glycolytic enzymes as CMA substrates
(Figure S5E). We also found an overrepresentation of TCA
cycle-related enzymes among the CMA substrates (Figures
S5E and S5F), suggesting that later steps in the catabolism of
glucose may also be modulated by CMA. For example, the
cytosolic form ofmalate dehydrogenase (Mdh1) undergoes lyso-
somal degradation in Ctr mice in both fed and starved condi-
tions, but not in L2AKO livers (Figures 5C–5F). Even some of
the mitochondria-resident TCA enzymes, such as citrate synthe-
tase (CS), also showed a profile characteristic of a CMA sub-
strate (Figure S5E). The higher content of CS observed in
the cytosol of L2AKO mice (Figure S5A) suggests that CMA
degradation of this nuclear-encoded enzyme in Ctr mice occurs
in the cytosol, presumably before its translocation into mito-
chondria. Transcriptome analysis indicated that overall, genes
involved in other carbohydrate metabolism-related pathways
showed minimal changes in transcript levels except for a signif-
icant reduction of some genes involved in glucose transport, a
potential compensatory response to the abnormally enhanced
glycolysis (see deposited data).
Next, we overexpressed glycolytic enzymes alone or in com-
bination in Ctr cells to confirm that the higher levels of glycolytic
enzymes in the L2AKO mice were sufficient to drive the higher
glycolytic rates observed in these cells. We found that enhanced
glycolysis uponCMAblockagewas not restricted to liver but also
occurs in other cell types. For example, mouse embryonic fibro-
blasts from constitutive L2AKO mice showed higher basal levels(G) Liver lactate content, n = 6.
(H) Activity of glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase
(I–K) Average extracellular acidification rates (ECAR) in primary hepatocytes fro
without addition (Basal, top) or after adding 2,4 dinitrophenol (2,4 DNP) to asse
enzymes in the same hepatocytes maintained in serum supplemented media.
(L) Immunoblot for the indicated glycolytic enzymes in liver homogenates from
quantification, values are expressed relative to values in Ctr mice, n = 3–4. GAPDH
kinase; Pyr Carb., pyruvate carboxylase. All values are mean + SEM. Difference
Figure S4.
Cell Meof lactate production (Figure 6A) and maintained higher basal
and maximal glycolytic capability than Ctr fibroblasts upon
serum removal (Figures 6B and 6C), allowing us to perform over-
expression experiments in control fibroblasts. Overexpression of
GAPDH or PK was sufficient to increase basal and inducible
glycolysis in Ctr fibroblasts, whereas overexpression of aldolase
only had a discrete effect (Figure 6D). Combined overexpression
of GAPDH and PK had an additive effect on glycolytic rates,
supporting that enhanced glycolysis in L2AKO livers was likely
a result of the cumulative effect of the higher levels of multiple
glycolytic enzymes in these mice. Conversely, we found that
partial knockdown of GAPDH and PK alone or in combination
in L2AKO MEFs (to bring their levels closer to those in Ctr cells)
reduced their elevated glycolysis (Figures 6E and 6F).
Lastly, to confirm that blockage of degradation of glycolytic
enzymes by CMA was sufficient to increase cellular glycolysis,
we transfected fibroblasts with plasmids coding for wild-type
GAPDH or a mutant GAPDH resistant to CMA degradation,
generated by disruption of the CMA-targeting motif by targeted
mutagenesis (Salvador et al., 2000). Time course analysis
after transfection revealed that although both forms of GAPDH
were expressed at similar levels, the overall content of mutant
GAPDH remained higher over time due to its inability to undergo
degradation (Figure 6G). These differences were even more
noticeable when comparing cytosolic fractions where the
GAPDH amenable to CMA degradation resides. We confirmed
that the increase in GAPDH activity in transfected cells was
significantly higher in those expressing the CMA-resistant
mutant GAPDH (Figure 6H), which also displayed higher lactate
levels (Figure 6I) and increased basal and inducible ECAR (Fig-
ure 6J). Overall, these findings support that compromised degra-
dation of glycolytic enzymes and their subsequent increase in
intracellular levels are responsible for the alterations in carbohy-
drate metabolism observed in L2AKO mice.
Hepatocyte CMA Blockage Alters Liver
Lipid Metabolism
The pronunced accumulation of lipids observed in livers of
L2AKOmice (Figure 2) prompted us to study possible alterations
in lipid metabolism in these animals and whether they could be
due to changes at the enzymatic level. The comparative proteo-
mic analysis in lysosomes from Ctr and L2AKO livers revealed
that almost 30% of the proteins identified as CMA substrates
participate in lipidmetabolism, predominantly in triglyceride syn-
thesis, steroid metabolism, and lipid binding and transport (Fig-
ures 5I, 7A, 7B, and S6A). We validated the presence of this sub-
set of lipid regulatory enzymes in the pool of lysosomes active for
CMA (Figure 7C) and also confirmed that the starvation-induced
increase in lysosomal degradation of these lipid metabolismin fed mice livers (n = 4).
m mice maintained in serum-supplemented (I) or serum-deprived (K) media
s inducible ECAR (Maximal, bottom) (n = 6). (J) Immunoblot for the indicated
24 hr starved mice. Three individual mice are shown. Right: Densitometric
, glyceraldehyde 3-phosphate dehydrogenase; Aldo, aldolase A; PK, pyruvate
s with Ctr were significant for *p < 0.05, **p < 0.01, and ***p < 0.001. See also
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CMA and Liver Metabolismenzymes was significantly reduced in L2AKO mice (Figures 7D
and S5B). For some enzymes, their lysosomal degradation was
also reduced in L2AKO mice even under fed conditions (Figures
7D and S5B). Accordingly, levels of many lipid metabolic
enzymes were increased in liver cytosolic fractions from these
animals (Figure S5A). Since we did not find significant changes
in the transcript levels for these enzymes between Ctr and
L2AKO mice (deposited data), we conclude that the higher con-
tent of enzymes involved in lipid metabolism in the livers of
L2AKO mice was a consequence of their reduced degradation
via CMA.
The increase in L2AKO mice of levels of lipogenic enzymes,
such as glycerol-3-phosphate dehydrogenase (GPD), correlated
with higher enzymatic activity (Figure 7E), but to assess the over-
all impact of these enzymatic changes on lipid metabolism, we
used isolated hepatocytes. We confirmed that L2AKO mice
hepatocytes had marked accumulation of lipids (Figure S6B),
increased content of enzymes involved in lipid metabolism (Fig-
ure S6C) and reduced lysosomal degradation for these enzymes
(Figure S6D). Consistent with the increase in lipogenic enzymes,
direct metabolic measurements revealed higher rates of TG
synthesis in cells with abrogated CMA activity (Figure 7F).
To further elucidate other factors that could contribute to the
hepatosteatosis observed in L2AKOmice, we analyzed possible
changes in mitochondrial lipid catabolism. Basal oxygen con-
sumption rates were comparable between Ctr and L2AKO hepa-
tocytes, but the maximal respiratory capacity of L2AKO cells
was significantly reduced (Figure S7A). Furthermore, L2AKO
cells failed to increase mitochondrial respiration in response to
a lipogenic challenge (Figures S7B and S7C) and displayed lower
rates of b-oxidation in these conditions (Figure S7D). We did
not find apparent changes in mitochondrial morphology by
morphometric analysis of liver electronmicrographs (Figure S7E)
or any signs of higher mitochondrial depolarization after costain-
ing hepatoctyes with MitoTracker (mitochondria mass) and
MitoCMXRos (polarized mitochondria) (Figure S7F). Mitochon-
drial flux through macroautophagy (mitophagy), analyzed by
changes in colocalization between MitoTracker-labeled mito-
chondria and the autophagosomal marker LC3 upon blockage
or not of autophagosome/lysosome fusion with vinblastine, re-
vealed that mitophagy was comparable in Ctr and L2AKOFigure 5. CMA Regulates Hepatic Levels of Carbohydrate Metabolism
(A) mRNA levels of the indicated glycolytic enzyme genes in livers from fed or
expressed relative to Ctr fed mice, n = 3.
(B) Schematic of the hypothetical changes in levels of proteins in lysosomes isola
before isolation. Proteins are classified depending on these changes as nonsub
Right: Representative electrophoretic pattern of lysosomes isolated from anim
staining. Arrows indicate examples of proteins in each of the categories indicate
(C) Immunoblot for the indicated glycolytic enzymes in the same lysosomal sampl
Pyr. Carb., pyruvate carboxylase; Eno1, enolase 1; Cath D, cathepsin D.
(D) Densitometric quantification of immunoblots as the ones shown in (C) and in F
mice (none), n = 2–5.
(E) Immunoblot for the indicated enzymes of liver homogenates from fed or 24 h
(F) Rates of lysosomal degradation of the indicated enzymes calculated by dens
(G) Comparative proteomics of the lysosomes from the four experimental group
based on their sensitivity to leupeptin (top) and percentage of CMA substrates bas
the presence of a CMA-targeting motif in their sequence in the group of leupept
(H and I) Distribution among cellular biological processes (H) and metabolic pro
Percentages in each group are shown, n = 3. All values are mean + SEM. Differe
***p < 0.001. See also Figure S5.
Cell Mecells (Figure S7G). Reduced maximal mitochondrial respiratory
capacity and b-oxidation in L2AKO hepatocytes did not seem
to be a primary defect in mitochondrial function, as the respira-
tory states of mitochondria isolated from Ctr and L2AKO mice
were equivalent (Figures S7H and S7I). Instead, we propose
that reduced lipid oxidation in L2AKO hepatocytes could be sec-
ondary to a combination of higher routing of FFAs toward lipo-
genesis and the observed decrease in intracellular TG break-
down (Figure 7G). Lastly, we also found a significant reduction
in the VLDL secretion rate in L2AKO livers (Figure 7H), which
along with enhanced lipogenesis and reduced lipid breakdown
could further contribute to the hepatosteatotic phenotype of
L2AKO mice.
DISCUSSION
Activation of hepatic CMA in response to prolonged starvation
has been known since the initial description of this form of selec-
tive autophagy (Cuervo et al., 1995; Wing et al., 1991), but the
role of CMA upregulation in liver physiology has remained un-
characterized due to the lack of experimental models for the
study of CMA blockage in vivo. In this work, through the gener-
ation of a mouse model with ablated CMA activity in the liver, we
have identified CMA as a regulator of hepatic metabolism and of
the adaptation of this organ to nutritional deprivation and exces-
sive dietary lipids by degrading enzymes involved in distinct
metabolic pathways.
The metabolic dysfunction observed upon blockage of hepat-
ic CMA in vivo suggests that the age-dependent decline in the
activity of this autophagic pathway may contribute to the ener-
getic deficiencies and reduced ability to adapt to changes in
nutrient intake of elders. The previously reported decrease in
gluconeogenic capacity and increase in the glycolytic activity
(Cao et al., 2001; Dhahbi et al., 1999) of the liver with age coin-
cide with our findings in the livers of L2AKO mice. The fact that
these mice did not present with insulin resistance typically de-
tected in old organisms is in agreement with the recently pro-
posed concept that insulin resistance is not causal in aging
but it rather constitutes a reactive protective mechanism to pre-
vent peripheral tissues from glucose overload (Barzilai and Fer-
rucci, 2012). It is plausible that other age-related changes, stillEnzymes in Response to Starvation
48 hr starved control (Ctr) and Albumin-Cre-L2Af/f (L2AKO) mice. Values are
ted from 24 hr starved Ctr and L2AKO mice injected or not with leupeptin 2 hr
strates (1), substrates for lysosomal degradation (2), and CMA substrates (3).
als in the indicated conditions and subjected to SDS-PAGE and SyproRuby
d in the scheme.
es as in (B). PK, pyruvate kinase; Mdh1, malate dehydrogenase 1, cytoplasmic;
igure 1J (for GAPDH). Values are expressed relative to values in untreated Ctr
r starved mice injected or not with leupeptin.
itometric quantification of immunoblots as the ones showin in (E), n = 2–5.
s described in (B). Percentage of proteins classified as lysosomal substrates
ed on their loss of sensitivity to leupeptin in L2AKO lysosomes (middle panel) or
in-sensitive proteins (bottom panel), n = 3.
cesses (I) of proteins classified as CMA substrates in the proteomic analysis.
nces with Ctr (*) or with fed (x) were significant for *x p < 0.05, **p < 0.01, and
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trigger this reactive response. Alternatively, the full extent of
the metabolic syndrome observed in old organism may be
dependent on changes with age in CMA activity in peripheral
tissues. Interestingly, we found that even when blockage of
CMA is restricted to liver, peripheral tissues such as WAT and
BAT were also affected. Although future studies are required
to elucidate the molecular basis of this intercommunication,
we found that circulating levels of ketone bodies (previously
shown to activate CMA [Finn and Dice, 2005]) were higher in
L2AKO mice upon prolonged starvation (Figure S7J), making
possible that some of the observed peripheral changes could
be consequence of ketone body-mediated upregulation of
CMA in these tissues. This augmented ketogenesis, despite
reduced b-oxidation in L2AKO mice, could originate from
excessive acetyl-CoA generated from enhanced glycolysis or
changes in amino acid metabolism that lead to higher levels
of ketogenic substrates.
Multiple mechanisms contribute to the regulation of enzymatic
activity, but rapid cessation of an enzymatic process requires
inactivation (by posttranslational modification or through endog-
enous inhibitors [Kim and Kyung Lee, 2012; Xiong and Guan,
2012]) or elimination of the active enzyme already present in
the cell. Elimination of enzymes by proteolysis, as described in
this work by CMA, allows for a more global effect on the compo-
sition of the subproteome directly involved in several metabolic
pathways. According to our proteomic analysis, starvation-
induced activation of CMA in the liver lowers the levels of at least
30 different enzymes. The overall outcome of these enzymatic
changes is a reduction in the use and storage of energy re-
sources by the liver (by reducing glycolysis, triglyceride, and
steroid synthesis) and an increase of their export and use by
peripheral tissues. In this work, we have focused on glucose
and lipid metabolism guided by the major phenotypic changes
observed in the liver of L2AKOmice. Some of the enzymes iden-
tified in this study as CMA substrates can also undergo degrada-
tion by the proteasome. Depending on the cellular conditions
and extracellular signals, degradation by one pathway may be
favored over another. Although some of the enzymes identified
as CMA substrates in this work reside in mitochondria, the fact
that they accumulate in cytosolic fractions upon CMA blockage,
and that we did not observe differences in rates of mitochondrial
degradation, supports that their degradation occurs during their
targeting to mitochondria. In fact, only nuclear encoded TCAFigure 6. Reduced Degradation of Glycolytic Enzymes Leads to Enhan
(A) Lactate content in mouse embryonic fibroblasts (right, n = 3) from control (Ct
(B) Average extracellular acidification rates (ECAR) in fibroblasts maintained in s
phenol (2,4 DNP) to assess inducible ECAR (n = 8).
(C) Time course of ECAR changes in same cells as in (B) (n = 8).
(D) Top: Immunoblot for indicated proteins from Ctr fibroblasts transfected with
Bottom: ECAR values for Ctr fibroblasts overexpressing the indicated glycolytic
(E and F) Left: Immunoblot for indicated enzymes from fibroblasts transduced
glycolytic enzymes individually or together (PK+GAP). Right: ECAR values over t
(G) Top: Immunoblot forMyc andGAPDH from total cellular lysates (homogenate)
MYC-tagged wild-type (WT) GAPDH or GAPDH bearing a mutated CMA targeting
total and cytosolic cellular fractions.
(H) Activity of GAPDH and (I) lactate levels in the same cells at indicated times p
(J) Average ECAR values in the same cells 24 hr posttransfection (n = 4). All valu
***p < 0.001.
Cell Meenzymes were detected as CMA substrates in the proteomic
analysis.
The pronounced metabolic changes in L2AKO mice could
be in part explained by the mutual influence and tight intercon-
nection between carbohydrate and lipid metabolism pathways.
Thus, changes in one pathway may force rerouting of metabo-
lites to a different pathway. For example, early glycolytic inter-
mediates, when elevated, could be shunted toward TG synthesis
via the glycerol-3-phosphate pathway. Similarly, an increase
in acetyl-CoA production resulting from enhanced glucose
oxidation can in part be utilized for fatty acid biosynthesis, further
contributing to steatosis.
In this work, we have identified that the consequences of
defective hepatic CMA activity go beyond the mere disruption
of protein quality control to include a compromised ability to
maintain metabolic homeostasis and to adapt to changing ener-
getic demands. This role in the regulation of liver metabolism
makes CMA a putative therapeutic target in common metabolic
disorders.EXPERIMENTAL PROCEDURES
Animals
Four- to six-month-old male C57BL/6 mice, wild-type or transgenic for Albu-
min-Cre (Jackson Laboratory), were used. L2AKO mice were generated as
detailed in the Supplemental Information using loxP insertion to delete the
exon region in the lamp2 gene that encodes for the LAMP-2A variant and
crossing this mice with Albumin-Cre mice (Jackson Laboratory) (Figure 1).
Conditions of diets and treatments are described in the Supplemental Informa-
tion. All genotyping, breeding and treatments in this study were done accord-
ing to protocol and all animal studies were under an animal study protocol
approved by the Institutional Animal Care and Use Committee of Albert
Einstein College of Medicine.Chemicals
Sources of chemicals and antibodies were used as described before (Kaushik
et al., 2006; Kiffin et al., 2004; Zhang and Cuervo, 2008). The source of the
antibodies used in this study and dilutions used for immnoblot and immunoflu-
orescence are detailed in the Supplemental Information.Subcellular Fractionation and Isolation of Lysosomes
Mouse liver lysosomes were isolated from a light mitochondrial-lysosomal
fraction in a discontinuous metrizamide density gradient, and a fraction
enriched in the subpopulation of lysosomes active for CMA was further
separated by differential centrifugation as previously described (Cuervo
et al., 1997). Lysosomal integrity was verified after isolation by measuringced Glycolysis in CMA-Defective Cells
r) and L2A/ (KO) mice.
erum-deprived media without addition (Basal, left) or after adding 2,4 dinitro-
plasmids coding for MYC-tagged GAPDH, Pyruvate Kinase (PK), or Aldolase.
enzymes individually or in combination, n = 4. OE, overexpression.
with a lentivirus carrying shRNA against GAPDH or PK to knock down (KD)
ime and (F) average ECAR values in the transduced cells (n = 4).
and cytosolic fractions fromCtr fibroblasts transfected with plasmids coding for
motif (MT). Bottom: Time course of changes of WT and MT GAPDH protein in
osttranfection (n = 3).
es are mean + SEM. Differences with Ctr (*) were significant for *p < 0.05 and
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Figure 7. Liver Enzymes Related to Lipid Metabolism Undergo Regulated Degradation by CMA
(A) Distribution among pathways related to lipidmetabolism of all proteins or proteins classified as CMA substrates through the comparative proteomic analysis of
lysosomes isolated from 24 hr starved control (Ctr) and Albumin-Cre-L2Af/f (L2AKO) mice injected or not with leupeptin 2 hr before isolation, n = 3.
(B) Fold increase in levels of the indicated proteins related to lipid metabolism in the same lysosomes after leupeptin treatment as determined in the comparative
proteomic analysis, n = 3.
(C) Immunoblot for the indicated enzymes related to lipid metabolism in the same lysosomal samples as in Figure 5B. GPD, glycerol-3-phosphate dehydro-
genase; ACADL, acyl-coenzyme A dehydrogenase long chain; Cyp27A1, cytochrome P450 cholesterol 27 hydroxylase; ACSL1, long-chain acetyl-coenzyme A
synthetase. Right: Quantification of immunoblots shown on left. Values are presented relative to values in untreated groups, n = 3–6.
(legend continued on next page)
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CMA and Liver Metabolismb-hexosaminidase activity latency, and only preparations with less than 10%
broken lysosomes were used (Storrie and Madden, 1990).
Histological Procedures and Electron Microscopy
Livers were fixed in 10% neutral buffered formalin and stained with H&E and
periodic acid-Schiff stain (PAS). For oil red O staining, liver tissue was frozen
in OCT, sectioned, and stained. For electron microscopy, livers were fixed
with 2% paraformaldehyde and 2% gluteraldehyde in 0.1 M sodium cacody-
late buffer. Details of processing and quantification are in the Supplemental
Information.
Metabolic Analysis
Bodycompositionwasdeterminedbymagnetic resonancespectroscopy (MRS)
using an Echo MRS instrument (Echo Medical System) and EE using metabolic
chambers as described in the Supplemental Information. Carbohydrate meta-
bolism was measured using glucose tolerance, insulin sensitivity and pyruvate
tolerance tests and liver and serum lipids were analyzed by chromatography
and enzymatic assays as described in the Supplemental Information.
Other Methods
Liver function was assessed with the Zoxazolamine-induced paralysis test as
described in the Supplemental Information (Zhang and Cuervo, 2008). Prote-
omic analysis was performed using iTRAQ multiplex (Applied Biomics) and
microarray analysis using Affymetrix technology and validated by real-time
PCR (see the Supplemental Information for details). The ALT levels were
measured in serum samples collected by retro-orbital bleed using a commer-
cial colorimetric assay (TECTO Diagnostics). For immunoblotting, protein con-
centration was determined by the Lowry method (Lowry et al., 1951) using
bovine serum albumin as a standard. After SDS-PAGE, gels were transferred
to nitrocellulose membranes using a Mini-TransBlot SD wet transfer cell (Bio-
Rad, Richmond, VA) and immunoblotting performed following standard proce-
dures (Towbin et al., 1979). Proteins recognized by the specific antibodies
were visualized by chemiluminescence (RenaissanceR; PerkinElmer Life and
Analytical Sciences) using peroxidase conjugated secondary antibodies in a
LAS-3000 Imaging System (Fujifilm). Densitometric quantification of the immu-
noblotted membranes was performed with ImageJ software.
Statistical Analysis
All values are reported as mean + SEM, and the statistical significance of the
difference between experimental groupswas determined in instances of single
comparisons by the two-tailed unpaired Student’s t test with the Sigma Plot
software (Jandel Scientific). In instances of multiple means comparisons, we
used one-way analysis of variance (ANOVA) followed by the Bonferroni
post-hoc test to determine statistical significance.
ACCESSION NUMBERS
Microarray data have been deposited in the GEO repository with accession
number GSE49553.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.cmet.2014.06.009.(D) Rates of basal and starvation-induced lysosomal degradation in percentage o
levels of the indicated proteins in lysosomes from animals treated or not with le
Figure S5B.
(E) Enzymatic activity of GPD in liver homogenates, n = 7.
(F) Average rates of newly synthesized radiolabeled TG in cells pulsed with 14C-g
(G) Rates of TG hydrolysis in cells incubated overnight with 14C-oleate and chas
(H) Serum triglyceride (TG) measured at the indicated times before and after treatm
n = 3–4.
(I) Schematic of the enzymes in the indicated carbohydrate and lipid metabolic p
whose levels increase when CMA is compromised in liver. All values are mean
**p < 0.01, and ***p < 0.001. See also Figures S6 and S7.
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